S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
NASDAQ:ICUI

ICU Medical (ICUI) Stock Forecast, Price & News

$184.46
+5.34 (+2.98%)
(As of 06/2/2023 ET)
Compare
Today's Range
$178.19
$184.60
50-Day Range
$156.00
$209.15
52-Week Range
$128.90
$212.43
Volume
144,368 shs
Average Volume
186,252 shs
Market Capitalization
$4.44 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$203.00

ICU Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
10.1% Upside
$203.00 Price Target
Short Interest
Bearish
5.71% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.47
Upright™ Environmental Score
News Sentiment
0.98mentions of ICU Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$121,610 Sold Last Quarter
Proj. Earnings Growth
37.66%
From $5.63 to $7.75 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.06 out of 5 stars

Medical Sector

459th out of 983 stocks

Surgical & Medical Instruments Industry

47th out of 98 stocks


ICUI stock logo

About ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

ICUI Stock News Headlines

We Called (ARWR) In Advance, Which Stocks Are Next?
Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.
ICU Medical's (ICUI) Maintains Rating Reiterated at 51job
ICU Medical (NASDAQ:ICUI) Rating Reiterated by 51job
The Medical Care That Helps No One
From -60% Account to Doubling His Money?
After helping his readers double their money 13 TIMES in the last year alone… There’s ONE person trader Jeff Clark has NOT been able to help! His 23-year-old son, Grant.
Q1 2023 ICU Medical Inc Earnings Call
ICU Medical Announces First Quarter 2023 Results
ICU Medical (ICUI) to Release Quarterly Earnings on Monday
See More Headlines

ICUI Price History

ICUI Company Calendar

Last Earnings
11/03/2021
Today
6/02/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ICUI
CUSIP
44930G10
Employees
14,500
Year Founded
1984

Price Target and Rating

Average Stock Price Forecast
$203.00
High Stock Price Forecast
$216.00
Low Stock Price Forecast
$190.00
Forecasted Upside/Downside
+10.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-74,290,000.00
Pretax Margin
-3.17%

Debt

Sales & Book Value

Annual Sales
$2.31 billion
Cash Flow
$17.35 per share
Book Value
$87.28 per share

Miscellaneous

Free Float
22,259,000
Market Cap
$4.44 billion
Optionable
Optionable
Beta
0.62

Social Links


Key Executives

  • Vivek JainVivek Jain
    Chairman & Chief Executive Officer
  • Christian B. Voigtlander
    Chief Operating Officer
  • Brian M. Bonnell
    Chief Financial Officer & Treasurer
  • Krishna Uppugonduri
    VP-Quality, Medical & Regulatory Affairs
  • Virginia SanzoneVirginia Sanzone
    Secretary, Vice President & General Counsel













ICUI Stock - Frequently Asked Questions

Should I buy or sell ICU Medical stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ICUI shares.
View ICUI analyst ratings
or view top-rated stocks.

What is ICU Medical's stock price forecast for 2023?

2 Wall Street analysts have issued 1-year price objectives for ICU Medical's shares. Their ICUI share price forecasts range from $190.00 to $216.00. On average, they expect the company's share price to reach $203.00 in the next year. This suggests a possible upside of 10.1% from the stock's current price.
View analysts price targets for ICUI
or view top-rated stocks among Wall Street analysts.

How have ICUI shares performed in 2023?

ICU Medical's stock was trading at $157.48 at the start of the year. Since then, ICUI stock has increased by 17.1% and is now trading at $184.46.
View the best growth stocks for 2023 here
.

When is ICU Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our ICUI earnings forecast
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) released its quarterly earnings data on Wednesday, November, 3rd. The medical instruments supplier reported $2.07 EPS for the quarter, beating analysts' consensus estimates of $1.57 by $0.50. The medical instruments supplier had revenue of $336.06 million for the quarter, compared to analyst estimates of $314.20 million. ICU Medical had a positive trailing twelve-month return on equity of 6.42% and a negative net margin of 2.00%. During the same quarter last year, the company posted $1.61 earnings per share.

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Wellington Management Group LLP (9.19%), BlackRock Inc. (7.30%), JPMorgan Chase & Co. (3.24%), State Street Corp (2.56%), Victory Capital Management Inc. (2.49%) and Nuance Investments LLC (2.14%). Insiders that own company stock include Daniel Woolson, Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends
.

How do I buy shares of ICU Medical?

Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $184.46.

How much money does ICU Medical make?

ICU Medical (NASDAQ:ICUI) has a market capitalization of $4.44 billion and generates $2.31 billion in revenue each year. The medical instruments supplier earns $-74,290,000.00 in net income (profit) each year or ($1.92) on an earnings per share basis.

How many employees does ICU Medical have?

The company employs 14,500 workers across the globe.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The official website for the company is www.icumed.com. The medical instruments supplier can be reached via phone at (949) 366-2183, via email at ir@icumed.com, or via fax at 949-366-8368.

This page (NASDAQ:ICUI) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -